Clare Pin-Chia Huang: New Research Links Maternal Diabetes to Pregnancy Risks
Clare Pin-Chia Huang, Associate Research Scientist, Epidemiology and Biostatistics at Flatiron Health, shared a post on LinkedIn about a paper published in Birth Defects Research:
“Grateful to share a new milestone: My first-authored paper is officially published!
This work, now live in Birth Defects Research, explores the impact of pregestational diabetes types on pregnancy loss and congenital malformations.
- What we found: In this study of over 2 million pregnancies, several critical insights emerged regarding maternal pregestational DM
- Elevated MCM Risk: Both T1DM and T2DM were associated with an over 60% increased risk of major congenital malformations (MCMs) overall.
- Specific Malformations: We observed a 100% increased risk for cardiovascular and central nervous system malformations specifically.
- Pregnancy Loss: Mothers with T2DM faced a higher risk of spontaneous abortion (21.7%) compared to those with T1DM (17.5%) and those without DM (15.9%).
- Impact of Progression: Within the T2DM group, the risk of MCM was highest among those on insulin therapy, which we used as a proxy for disease progression.
I hope this paper provides valuable evidence for clinical counseling and fosters further research into tailored management strategies for pregnant women with pregestational diabetes.”
Title: Maternal Diabetes Types and the Risk of Pregnancy Loss and Specific Malformations in the Infant
Authors: Pin-Chia Huang, Krista F. Huybrechts, Loreen Straub, Jeremy P. Brown, Brian Bateman, Sonia Hernández-Díaz
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic